Florida generic drugmaker Apotex signed a deferred prosecution agreement today with the US Department of Justice and will pay $24.1 million to settle a criminal case over price-fixing of the cholesterol drug pravastatin.Apotex's three-year DPA was announced by the DOJ (see here). The company is the fourth to settle criminal charges in